APA

McCarthy C. E., O'Brien M., Andrews J., Zoland J. M., Macasiray E., Wong W., Lo C., Glader B., Tamaresis J. & Jeng M. (20161213). Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator. : Haemophilia : the official journal of the World Federation of Hemophilia.

Chicago

McCarthy C E, O'Brien M, Andrews J, Zoland J M, Macasiray E, Wong W, Lo C, Glader B, Tamaresis J and Jeng M. 20161213. Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator. : Haemophilia : the official journal of the World Federation of Hemophilia.

Harvard

McCarthy C. E., O'Brien M., Andrews J., Zoland J. M., Macasiray E., Wong W., Lo C., Glader B., Tamaresis J. and Jeng M. (20161213). Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator. : Haemophilia : the official journal of the World Federation of Hemophilia.

MLA

McCarthy C E, O'Brien M, Andrews J, Zoland J M, Macasiray E, Wong W, Lo C, Glader B, Tamaresis J and Jeng M. Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator. : Haemophilia : the official journal of the World Federation of Hemophilia. 20161213.